Evidence map›Paper›PMID 22914737›Full record

ReviewHuman molecular genetics2012

COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets.

Debbie S Kuo, Cassandre Labelle-Dumais, Douglas B Gould

Open access · hybridAbstract readReview
In one paragraph

Review in Human molecular genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 185 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
185citing papers in PubMed, 5 pooled it
8.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

185 citing papers in PubMed, 5 syntheses or guidelines pooled it, 310 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Genetics of intracerebral hemorrhage.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  13. Article
  14. Vascular contribution to cognitive impairment and dementia (VCID): proceedings of 2025 workshop of the Jackson Laboratory.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Article
  15. Article
  16. Article
  17. Novel COL4A2 splice-site variant associated with cerebral small vessel disease and progressive leukoencephalopathy.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  18. Article
  19. Article
  20. Article

125 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Debbie S KuoDepartment of Ophthalmology, UCSF School of Medicine, San Francisco, CA 94143, USA.
Cassandre Labelle-Dumais
Douglas B Gould
University of California, San Francisco · US

Funding

Rapid-Prototyping and Design CoreP30EY002162 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LAKKARAJU, APARNA · 1985 to 2024
$16.8M
Genetically testing mechanisms of ocular development and diseaseR01EY019887 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Douglas Gould · 2010 to 2026
$5.5M
Genetically testing interactions of ER and oxidative stresses in retinal diseaseR01EY019514 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GOULD, DOUGLAS · 2009 to 2013
$1.9M
Howard Hughes Medical InstituteNEI NIH HHS P30 EY002162NEI NIH HHS R01 EY019514NEI NIH HHS R01EY019514NEI NIH HHS R01 EY019887NEI NIH HHS R01EY019887
6 · The paper itself

Abstract

Heterotrimers composed of collagen type IV alpha 1 (COL4A1) and alpha 2 (COL4A2) constitute one of the most abundant components of nearly all basement membranes. Accordingly, mutations in COL4A1 or COL4A2 are pleiotropic and contribute to a broad spectrum of disorders, including myopathy, glaucoma and hemorrhagic stroke. Here, we summarize the contributions of COL4A1 and COL4A2 mutations in human disease, integrate knowledge gained from model organisms and evaluate the implications for pathogenic mechanisms and therapeutic approaches.

Indexed as

AnimalsBasement MembraneBiological TransportCollagen Type IVGenetic Predisposition to DiseaseGlaucomaHumansMiceMolecular Targeted TherapyMuscular DiseasesMutationPhenotypeProtein MultimerizationStrokeCOL4A1 protein, humanCOL4A2 protein, humanCollagen Type IV

Identifiers

PMID22914737
PMCPMC3459649
OpenAlexW2162695141

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.